Want to join the conversation?
$BCR 2Q15 Call: PMA supplement for 120/150 mm balloon lengths was recently approved & received IDE approval, enrolled first few patients in AV access drug-coated balloon study. We're also working toward launch in 1H16 of next generation of both PowerGlide &AccuCath products. For acute hemodialysis patients, recently launched Trialysis Slim catheter
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?
$AVGO 4Q results beat analyst’s expectations again this time. Time to make some hay while the sun shines ;)